Latest news with #ToltraMax
Entrepreneur
3 days ago
- Business
- Entrepreneur
How This Entrepreneur Is Disrupting Pet Health
When Andrew Hamilton set out to launch his vision went far beyond building a convenient online pharmacy. For Hamilton, a seasoned entrepreneur with a passion for improving access to veterinary care, it was personal. Opinions expressed by Entrepreneur contributors are their own. You're reading Entrepreneur Asia Pacific, an international franchise of Entrepreneur Media. When Andrew Hamilton set out to launch his vision went far beyond building a convenient online pharmacy. For Hamilton, a seasoned entrepreneur with a passion for improving access to veterinary care, it was personal. His own experiences navigating the complexities of pet health inspired him to create not just a platform — but also a solution. The first solution came in the form of ToltraMax, an oral toltrazuril-based treatment developed by Hamilton and his team to address one of the most persistent yet overlooked challenges in animal health: coccidiosis. Coccidiosis, caused by microscopic parasites called Eimeria, is a common intestinal issue that affects pets, livestock, and companion animals alike. For breeders, veterinarians, and everyday pet owners, managing outbreaks of this parasite can be costly, time-consuming, and stressful. Hamilton saw a clear need for a more practical, widely applicable treatment option — one that was effective, accessible, and simple to administer. That's how ToltraMax was born. Innovating Where It Matters Most Unlike many entrepreneurs who focus solely on platform technology, Hamilton dove into product development. Together with his team, he formulated ToltraMax as a high-concentration (10%) toltrazuril oral solution designed for companion animal use — including dogs, cats, horses and other non foodchain animals. The goal wasn't to compete with pharmaceutical giants on brand recognition. It was to create a tool that addressed real problems in the field, offering animal caretakers a reliable option to support intestinal health related to coccidia. ToltraMax is currently available through and where it has found a strong foothold among pet and equine caretakers. However, its broader applications make it a natural fit for the direct-to-consumer model that Hamilton envisions for plugins and affilate programs. Building the Infrastructure for Accessible Care set to launch later this year, represents Hamilton's larger vision: an integrated platform where pet owners can access trusted medications, telehealth support, and educational resources in one place. "We created ToltraMax because there was a treatment gap in the market," Hamilton explains. "But creating the product is only half the battle. The real challenge is making sure people can actually get it when they need it quickly." That challenge is exactly what is working to address. With additional generic drug applications currently pending, is preparing to expand its offerings and close more of these critical gaps in animal healthcare. Earlier this year, Hamilton secured $21 million in funding from Palehorse Capital to support development and expansion. The investment reflects growing recognition of the need for affordable, accessible veterinary solutions — especially as pet ownership rises and traditional access points remain limited. More Than a Product: A Founder's Mission While ToltraMax serves as flagship offering, Hamilton sees it as the first step in a much larger journey. By controlling both the product development and distribution channels, he aims to eliminate common barriers pet owners face, from high medication costs to lack of availability. won't replace vet visits — a point Hamilton emphasizes often. Instead, it will work hand in hand with licensed veterinarians to provide a trusted pathway for pet owners to access products like ToltraMax, while encouraging responsible use through teleconsultations and professional guidance. "Our focus is on supporting pet owners and veterinarians with better tools," Hamilton says. "ToltraMax reflects that philosophy — it's practical, effective, and designed with real-world challenges in mind." What's Next As the platform prepares for launch, Hamilton remains focused on scaling responsibly, ensuring that both the product and the platform maintain the high standards he set out to establish. Hamilton's approach offers a compelling case study in vertical integration: identify a problem, create a solution, and build the infrastructure to deliver it. In a crowded digital health market, his model of product-plus-platform stands out. For pet owners and veterinary professionals, it's a welcome sign of things to come.
Associated Press
17-05-2025
- Business
- Associated Press
Vetr Announces Plans to Offer ToltraMax Oral Solution Upon Platform Launch
GRANTS PASS, OR, May 16, 2025 (EZ Newswire) -- Vetr, an upcoming telehealth platform focused on providing pet owners with access to veterinary products and services, has announced its intention to include ToltraMax, a toltrazuril-based oral solution, as part of its product offerings when the platform launches later this year. ToltraMax is an oral solution formulated for use in multiple species, including dogs, cats, horses and other non food chain animals. Its active ingredient, toltrazuril, is widely used in veterinary settings to manage intestinal health challenges related to coccidia, a common protozoan parasite affecting a variety of animals. While Vetr's platform is still in development, ToltraMax is currently available for purchase through Amazon, Walmart, and serving caretakers of equine and companion animals. 'Expanding access to essential veterinary products is a core part of Vetr's mission,' said Andrew Hamilton, founder and CEO of Vetr. 'ToltraMax aligns with our goal of providing practical, broad-use solutions and compounded drugs for pet owners and animal caretakers, making it an important addition to our future product lineup.' Vetr aims to simplify the process of obtaining veterinary-recommended medications through a digital platform designed for convenience and accessibility. The platform will offer an online pharmacy, educational resources, and telehealth consultations, supporting responsible pet care and providing guidance on product usage. Recently, Vetr secured $21 million in funding from Palehorse Capital to support the platform's development and product expansion, including a nationwide online pharmacy. This investment will assist in launching a comprehensive online marketplace for veterinary products, including ToltraMax, alongside efforts to lower the overall cost of pet medications for consumers. Upon launch, Vetr will provide pet owners with a streamlined purchasing experience, while emphasizing the importance of professional veterinary consultation. The platform will not replace veterinary care but will serve as an additional resource for accessing trusted products and information. For updates on Vetr's launch and product availability, visit About Vetr Vetr is a telehealth platform transforming pet healthcare by making veterinary services more affordable, accessible and efficient. Through its easy-to-use app, pet owners can schedule appointments, consult remotely with licensed veterinarians and access low-cost, over-the-counter animal prescriptions. Founded by Andrew Hamilton, Vetr is dedicated to delivering high-quality, cost-effective care for pets nationwide. With a focus on generic medications and virtual care, Vetr is redefining how modern pet owners manage their animals' health. Learn more at Media Contact Media Relations [email protected] ### SOURCE: Vetr Copyright 2025 EZ Newswire
